Actavis in talks to buy Forest Labs for up to $25 bln

Actavis is in advanced talks to acquire rival drug maker Forest Laboratories, according to people familiar with the matter.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.